Reply to ‘Evidence-based review, not change in usage patterns, should drive Medicare Benefit Schedule (MBS) disinvestment decisions’
Linda Mundy
+ Author Affiliations
- Author Affiliations
Queensland Health, Level 2, 15 Butterfield Street, Herston, Qld 4029, Australia. Email: linda.mundy@health.qld.gov.au
Australian Health Review 41(6) 715-716 https://doi.org/10.1071/AH16239
Submitted: 24 October 2016 Accepted: 28 October 2016 Published: 5 December 2016
References
[1] Orchard JW, Orchard JJ, Damra DJ. Evidence-based review, not change in usage patterns, should drive Medicare Benefit Schedule (MBS) disinvestment decisions. Aust Health Rev 2016;| Evidence-based review, not change in usage patterns, should drive Medicare Benefit Schedule (MBS) disinvestment decisions.Crossref | GoogleScholarGoogle Scholar |
[2] Mundy L. Platelet-rich plasma: a case study for the identification of disinvestment opportunities using horizon scanning. Aust Health Rev 2016;
| Platelet-rich plasma: a case study for the identification of disinvestment opportunities using horizon scanning.Crossref | GoogleScholarGoogle Scholar |
[3] Mundy L, Merlin TL, Parrella A, Babidge WJ, Roberts DE, Hiller JE. The Australia and New Zealand horizon scanning network. Aust Health Rev 2005; 29 395–7.
| The Australia and New Zealand horizon scanning network.Crossref | GoogleScholarGoogle Scholar |
[4] Laudy AB, Bakker EW, Rekers M, Moen MH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med 2015; 49 657–72.
| Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis.Crossref | GoogleScholarGoogle Scholar |
[5] Medical Services Advisory Committee (MSAC). Intra-articular viscosupplementation for treatment of osteoarthritis of the knee. Canberra: MSAC; 2003. Available at: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/6597E1FBFD707643CA25801000123B71/$File/1045-Assessment-Report.pdf [verified 8 July 2013].
[6] Schmajuk G, Bozic KJ, Yazdany J. Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections. JAMA 2014; 174 1702–4.
[7] Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013; 41 356–64.
| Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial.Crossref | GoogleScholarGoogle Scholar |
